Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Sleep Cycle AB ( (SE:SLEEP) ) is now available.
Sleep Cycle’s independent board members have unanimously advised shareholders to reject a SEK 24.50 per share cash takeover bid from Altor-controlled Snark BidCo, valuing the company at about SEK 497 million and offering a near 50% premium to recent trading levels. The board argues the bid undervalues Sleep Cycle’s strong cash-generating subscription model and its ongoing strategic investments, which are expected to significantly improve growth, revenue diversification and earnings over time.
Directors highlight early traction in medical applications, including substantial interest in its sleep apnea offering and ongoing clinical validation within an established regulatory framework. They also point to rapid expansion in technology licensing, with B2B revenue up 42% year-on-year in Q1 2026 and now accounting for 14.5% of total sales, and contend that even in a low-growth, cash-focused run-off scenario the company’s value would match or exceed the offer, implying limited recognition of its future growth potential in the current bid.
More about Sleep Cycle AB
Sleep Cycle AB is a Sweden-based sleep technology company focused on subscription-based digital sleep tracking and analytics services. The company is expanding beyond consumer sleep monitoring into medical applications, such as sleep apnea detection, and technology licensing, targeting scalable B2B recurring revenue streams in the broader wellness and health-tech market.
Average Trading Volume: 56,323
Technical Sentiment Signal: Buy
Current Market Cap: SEK491.7M
See more data about SLEEP stock on TipRanks’ Stock Analysis page.